Kyntra Bio, Inc.
KYNB· Nasdaq
KYNBKyntra Bio, Inc.
Filed Mar 1, 2017 · 10-K · 60 days after period end · 0001564590-17-003095
derived · Computed from the longer spans the company filed.
| Metric | Q4 2016dderived from reported figures | Q4 2015dderived from reported figures | Q4 2014dderived from reported figures |
|---|---|---|---|
| Revenue | $35.53M | $24.44M | $16.11M |
| Net Income | -$30.39M | -$51.37M | -$50.56M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kyntra Bio, Inc. · CIK 921299 · Engraved from SEC EDGAR
ended Dec 31, 2016 · filed Mar 1, 2017 · 60 d after period end
